Dysregulation of cytokine levels, particularly those of TNF, IL-17, and granulocyte–macrophage colony-stimulating factor (GM-CSF), contributes to the pathogenesis of MS (Amoriello et al., 2024). This evidence concerns the gene CSF2 and myeloid sarcoma.